PIT2 stands for Proteomic and Innovation Technologique Timone. PIT2-CRO2 is part of the platform Marseille Protéomique (MaP), arisen from the will of four service and research platforms (CRN2M, IMM, CRCM, PIT2-CRO2). MaP aims to achieve a better visibility and boost of ambitious scientific projects.
PIT2 is a proteomic research group for basic and clinical research based on the La Timone Campus in Aix-Marseille University. It is the research group of the research center for oncology and oncopharmacology of Aix-Marseille University (CRO2).
CRO2 is formed by a multidisciplinary team of researchers, academics and clinicians (both doctors and pharamcists) and it is composed by six research teams from the french institute INSERM and Aix-Marseille University. They are mainly specialized in cancerology with proteomic, animal nursing, flow cytometry and imaging facilities.
The main Research topics are glioma, pancreas cancer, microtubules, plus-end proteins, tau protein and cancer, oxidation and cancer, pharmacoproteomics and MALDI imaging of tumors.